期刊文献+

瑞舒伐他汀对兔动脉内皮损伤后转化生长因子β1表达的影响 被引量:1

Effect of Rosuvastatin on Expression of Transforming Growth Factor β1 in Dorsal Aorta of Rabbits After Balloon Injury
下载PDF
导出
摘要 目的探讨瑞舒伐他汀对兔腹主动脉球囊损伤后转化生长因子β1表达的影响。方法新西兰兔20只随机分为瑞舒伐他汀组和模型组,两组均应用球囊损伤腹主动脉方法建立兔血管内皮损伤模型,术后6周行腹主动脉造影后采用免疫组织化学法和逆转录聚合酶链反应技术对兔腹主动脉壁转化生长因子β1表达的情况进行观察。结果瑞舒伐他汀组血管狭窄程度(31.41%±7.08%)、血管狭窄段最小内径(1.74±0.25 mm)明显优于模型组(分别为55.25%±10.23%和1.32±0.33 mm),两组比较差异有统计学意义(P<0.05);瑞舒伐他汀组转化生长因子β1平均吸光度(0.41±0.12)、阳性细胞面积(31.37%±4.42%)均低于模型组(0.57±0.17和40.58%±7.45%,P<0.05),损伤血管中转化生长因子β1 mRNA表达(22.37±4.42)较模型组(42.47±5.41)明显减弱(P<0.05)。结论瑞舒伐他汀对内皮损伤后的血管病变有保护作用,其机制可能是部分通过下调转化生长因子β1的表达,减轻血管球囊损伤后再狭窄。 Aim To evaluate the effect of rosuvastatin on restenosis and the expression of transforming growth factor β1(TGF-β1) in abdominal aorta of rabbits after balloon injury. Methods Two groups of 10 male New Zealand rabbits received either rosuvastatin or no rosuvastatin after balloon injury.We did abdominal aorta angiography and observed the expression of TGF-β1 with immunohistochemistry and reverse transcription polymerase chain reaction(RT-PCR) six weeks later. Results The average stenosis degree(31.41%±7.08%) and the smallest inner diameters(1.74±0.25 mm) were better in rosuvastatin-treated group than that of the model group(55.25%±10.23% and 1.32±0.33).The average absorbency and the area of positive of TGF-β1 were dramatically lower in rosuvastatin-treated group than that of the model group(0.41±0.12 vs 0.57±0.17,31.37%±4.42% vs 40.58%±7.45%);The quantity of amplification products(22.37±4.42) was lower than that of the model group(42.47±5.41),there were significant differences between the two groups(P0.05). Conclusion Rosuvastatin can improve the restenosis and decrease the expression of TGF-β1 in rabbits after balloon injury.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2011年第8期637-640,共4页 Chinese Journal of Arteriosclerosis
基金 河北省医学科学研究重点课题计划资助项目(20100158)
关键词 瑞舒伐他汀 转化生长因子Β1 内皮损伤 再狭窄 冠心病 Rosuvastatin Transforming Growth Factor β1 Balloon Injury Restenosis Coronary Heart Disease
  • 相关文献

参考文献12

  • 1Baigent C, Keech A, Keamey PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins[ J]. Lan- cet, 2005, 366:1 26%278.
  • 2Liao JK. Effects of statins on 3-bydroxy-3-methylglutaryl eoenzyme a reductase inhibition beyond low-density lipoprotein cholesterol [ J ]. Am J Cardiol, 2005, 96 : 24F-33F.
  • 3Lablanche JM, Leone A, Merkely B, et al. Comparison of the effi- cacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/ apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study[J]. Arch Cardiovasc Dis, 2010, 103(3) : 160-169.
  • 4Nicholls SJ, Brandrup-Wognsen G, Palmer M, et al. Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosu- vastatin versus simvastatin on lowering levels of atherogenic lipids (from VOYAGER) [J]. Am J Cardiol, 2010, 105(1) : 69-76.
  • 5刘平,李永红,苘瑜琳,蔡尚郎.球囊损伤大鼠主动脉内皮后血管紧张素Ⅱ2型受体的表达及瑞舒伐他汀的干预作用[J].中国动脉硬化杂志,2010,18(9):709-712. 被引量:2
  • 6Sironi L, Gianazza E, Gelosa P, et al. Rosuvastatin, but not simv- astatin, provides end-organ protection in stroke-prone rats by antiin- flammatory effects[ J ]. Arterioscler Thromb Vasc Biol, 2005,25 : 598-603.
  • 7徐建欧,陈小芬,卢益中.瑞舒伐他汀对不稳定型心绞痛患者高敏C反应蛋白的影响[J].南方医科大学学报,2010,30(5):1195-1196. 被引量:18
  • 8Chen J, Li D, Schaefer RF, et al. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice : novel insights into the role of RAS and dyslipidemia in athero- genesis~ J]. J Cardiovasc Pharmaeol, 2004, 44 : 446-452.
  • 9Veronica DA, Martin D, Lukas E, et al. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloprotein- ase-2 activity in normocholesterolemic and hypercholesterolemic rab- bits[J]. J Cardiovasc Pharmacol, 2009, 53: 137-144.
  • 10Michael SK, Haralampos JM, Moses SE. An overview of the extra- lipid effects of rosuvastatin [ J ]. J Cardiovasc Pharmacol Therapeu- tics, 2008,13 : 157-174.

二级参考文献19

共引文献27

同被引文献15

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部